CDEK
← All organizations

Mitsubishi

For profitContributed to NME

Also known as: Information at Mitsubishi Pharma America | Information at Mitsubishi Pharma Europe | Mitsubishi Logistics Corporation

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Aug 1, 2005

Last known activity

Jan 8, 2019

Acquired by Mitsubishi Tanabe on Jan 1, 1999

Timeline

1920s

  1. Jan 1, 1921

    Mitsubishi— Founded

1990s

  1. Jan 1, 1999

    Mitsubishi Tanabe— Acquired By

Drugs by trial phase (8 distinct, 12 trials)

Phase 3 (4 own, 0 via acquisition)

Phase 2 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (12)

  • NCT03809650CollaboratorPhase 3Jan 8, 2019
  • NCT00861692Overall official - principal investigatorPhase 2Apr 1, 2009
  • NCT00858637Overall official - principal investigatorPhase 3Mar 1, 2009
  • NCT00821821Study chairPhase 2Feb 1, 2009
  • NCT00772382Overall official - principal investigatorPhase 3Dec 1, 2008
  • NCT00542386Overall official - principal investigatorPhase 3Dec 1, 2007
  • NCT00542815Overall official - principal investigatorPhase 3Nov 1, 2007
  • NCT00506441Overall official - principal investigatorPhase 3Sep 1, 2007
  • NCT00416520Overall official - principal investigatorPhase 3Jun 1, 2007
  • NCT00451295Overall official - principal investigatorPhase 3May 1, 2007
  • NCT00307749Overall official - principal investigatorPhase 2Mar 1, 2006
  • NCT00508924Overall official - principal investigatorPhase 2Aug 1, 2005

Details

Founded
Higashi-Yoshitomi-mura, JP Jan 1, 1921
Last known activity
Jan 8, 2019